摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4R,4aS,7aR)-4-methyl-7a-(((R)-N-methyl-S-phenylsulfonimidoyl)methyl)-hexahydrocyclopent[d][1,3]oxazin-2(1H)-one | 942598-45-0

中文名称
——
中文别名
——
英文名称
(4R,4aS,7aR)-4-methyl-7a-(((R)-N-methyl-S-phenylsulfonimidoyl)methyl)-hexahydrocyclopent[d][1,3]oxazin-2(1H)-one
英文别名
——
(4R,4aS,7aR)-4-methyl-7a-(((R)-N-methyl-S-phenylsulfonimidoyl)methyl)-hexahydrocyclopent[d][1,3]oxazin-2(1H)-one化学式
CAS
942598-45-0
化学式
C16H22N2O3S
mdl
——
分子量
322.428
InChiKey
AAUJGTXFAYZATN-DCNSGQDGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.81
  • 重原子数:
    22.0
  • 可旋转键数:
    3.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.56
  • 拓扑面积:
    67.76
  • 氢给体数:
    1.0
  • 氢受体数:
    4.0

反应信息

  • 作为反应物:
    描述:
    (4R,4aS,7aR)-4-methyl-7a-(((R)-N-methyl-S-phenylsulfonimidoyl)methyl)-hexahydrocyclopent[d][1,3]oxazin-2(1H)-one正丁基锂1-氯乙基氯甲酸酯 作用下, 以 四氢呋喃正己烷二氯甲烷 为溶剂, 反应 60.0h, 生成 (3aS,4R,11S,11aR)-11-chloro-4-methyl-2,3,3a,4,8,9,10,11-octahydrocyclopenta[d]pyrido[1,2-c][1,3]oxazin-6(1H)-one
    参考文献:
    名称:
    Modular Asymmetric Synthesis of Functionalized Azaspirocycles Based on the Sulfoximine Auxiliary
    摘要:
    A modular asymmetric synthesis of the functionalized azaspirocycles 6 (m = 2, n = 1), 7 (m = 1, n = 2), 8 (m = n = 2), 12, 20, and 24 from the cyclic allylic sulfoximines 1 is described. The synthetic strategy is based on the stereoselective construction of the carbocycle 4 containing the amino-substituted tertiary C atom from 1 followed by the generation of the azaspirocycle. Three different routes have been followed for the synthesis of the heterocyclic ring: N,C-dianion cycloalkylation, ring-closing metathesis, and N-acyl iminium ion formation.
    DOI:
    10.1021/ol0706410
  • 作为产物:
    描述:
    (R)-1-((1S,Z)-2-{[(R)-N-methylphenylsulfonimidoyl]methylene}cyclopentyl)ethyl carbamate 在 正丁基锂 作用下, 以 四氢呋喃正己烷 为溶剂, 反应 12.0h, 以1.56 g的产率得到(4R,4aS,7aR)-4-methyl-7a-(((R)-N-methyl-S-phenylsulfonimidoyl)methyl)-hexahydrocyclopent[d][1,3]oxazin-2(1H)-one
    参考文献:
    名称:
    Modular Asymmetric Synthesis of Functionalized Azaspirocycles Based on the Sulfoximine Auxiliary
    摘要:
    A modular asymmetric synthesis of the functionalized azaspirocycles 6 (m = 2, n = 1), 7 (m = 1, n = 2), 8 (m = n = 2), 12, 20, and 24 from the cyclic allylic sulfoximines 1 is described. The synthetic strategy is based on the stereoselective construction of the carbocycle 4 containing the amino-substituted tertiary C atom from 1 followed by the generation of the azaspirocycle. Three different routes have been followed for the synthesis of the heterocyclic ring: N,C-dianion cycloalkylation, ring-closing metathesis, and N-acyl iminium ion formation.
    DOI:
    10.1021/ol0706410
点击查看最新优质反应信息

文献信息

  • Sulfoximine-Based Modular Enantioselective Synthesis of Azaspirocycles Featuring Sulfoximine Displacement, Dianion Cycloalkylation, RCM and<i>N</i>-Acyliminium Ion Formation
    作者:Adeline Köhler née Adrien、Gerhard Raabe、Jan Runsink、Franz Köhler、Hans-Joachim Gais
    DOI:10.1002/ejoc.201400068
    日期:2014.6
    Ring-closing metathesis of a bicyclic C,N-dienyl derivative furnished the corresponding spirocycle with an unsaturated piperidine ring. Cyclisation of an acetal group containing bicyclic oxazinanone gave spirocycles containing O,N-acetal and enamide groups. The diastereoselective reaction of a spirocyclic O,N-acetal with an allylsilane furnished the corresponding spirocycle, carrying an allyl group at the
    我们描述了具有一系列环尺寸的功能化氮杂螺环的模块化、对映选择性合成。该合成利用了亚砜亚胺的特殊特性,包括手性、碳负离子稳定、亲核性和疏核性。通过氨基甲酸酯方法对羟烷基取代的环烯基亚砜亚胺进行非对映选择性分子内胺化得到含有基取代的叔 C 原子的双环恶嗪酮。用双亲电试剂对相应的 C,N-二价阴离子进行环烷基化得到亚砜亚胺取代的螺环。用具有双键和缩醛基团的官能化亲电试剂对 C,N-二价阴离子进行单烷基化,得到相应的 C-烷基化双环亚砜亚胺。通过卤甲酸酯反应置换双环和螺环亚砜亚胺的亚砜亚胺基团得到相应的卤化物(Cl,I)。双环卤化物与官能化酸盐的烷基化和亚砜亚胺取代的双环的还原,在 Cα 原子上带有一个烷基,为逐步构建杂环提供了起始材料。双环 C,N-二烯基衍生物的闭环复分解为相应的螺环提供了一个不饱和的哌啶环。含有双环恶嗪酮的缩醛基团的环化得到含有 O,N-缩醛和烯酰胺基团的螺环。螺环 O,
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)